Industrial & Manufacturing Blog
- Blog: Patent 213Yet Another Pharmaceutical Patent Falls Under the Scrutiny of 35 U.S.C. § 112Posted on November 12, 2019 by Stephanie D. ScruggsLast week, the Federal Circuit confirmed that Idenix Pharmaceuticals will not be the proud recipient of what was previously regarded as the largest damages award ever recorded in a U.S. patent case. In fact, the majority’s opinion in Idenix Pharmaceuticals LLC v. Gilead Sciences Inc. not only affirmed the district court’s grant of judgment as...
- Blog: Antitrust UpdateClasses Certified in In re Suboxone “Product-Hopping” CasePosted on November 5, 2019 by William F. Cavanaugh, Jr., Amy N. Vegari, Ph.D.Recently, Judge Goldberg in the Eastern District of Pennsylvania certified two classes of plaintiffs asserting antitrust claims based on alleged “product hopping” by the manufacturer of branded tablets treating opioid addiction. In re: Suboxone (Buprenorphine Hydrochloride and Nalaxone) Antitrust Litig., 13-md-2445, 2019 U.S. Dist. LEXIS 166524 (E.D. Pa. Sept. 26, 2019). While declining to certify [...]